Has Vidushi Soni received payments from drug or device companies?

Yes. Drug and device makers reported $2,238 in general payments to Vidushi Soni across 65 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vidushi Soni did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vidushi Soni come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vidushi Soni

Internal Medicine · Sun City, AZNPI 1306924246

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,157 and has fallen 98.8% since, to $14 in 2023.

$2,238in general payments, 2019–2025

Across 65 payments — averaging $34.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$378
Pfizer$353
GSK$240
Amarin Pharma, Inc.$226
Amgen$169
AstraZeneca$140
plus $732 from 17 others

What the payments were for

Food & beverage$2,238100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	9	$378
Pfizer	12	$353
GSK	3	$240
Amarin Pharma, Inc.	7	$226
Amgen	3	$169
AstraZeneca	4	$140
Daiichi Sankyo Inc.	2	$136
Novo Nordisk	1	$94
Abbott	3	$85
Boehringer Ingelheim	3	$61
E.r. Squibb & Sons, L.L.C.	1	$51
Radius Health, Inc.	2	$44
Philips North America LLC	2	$40
Lilly USA, LLC	2	$37
Merck	2	$35
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$26
GE HealthCare	1	$24
Astellas Pharma US Inc	1	$23
Eisai Inc.	1	$22
Gilead	1	$16
Abiomed	1	$14
Alfasigma USA, Inc.	1	$13
Novartis	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,238 in reported general payments places this provider in the 85th percentile of 2,212 internal medicine providers in Arizona.

See all internal medicine providers in Arizona →

Other internal medicine in Sun City

Frank LovecchioPhoenix$911K
Nasser HajaigPhoenix$687K
Rajesh JanardhananTucson$685K
Mona SelejTucson$440K
Kelly KrohnPhoenix$262K
Jacque SokolovScottsdale$235K
Paul StanderPhoenix$222K
Howard GrossmanPhoenix$131K
Christine HarterGlendale$127K
Nafis Shamsid-DeenPhoenix$115K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →